Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis of a shared antibody response to SARS-CoV-2. | Science | 2020 | 32661058 | PubTator, text mining | PubMed |
| The Changing Landscape of Autoimmune Hemolytic Anemia. | Front Immunol | 2020 | 32655543 | PubTator, text mining | PubMed |
| Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib. | Leukemia | 2020 | 32655145 | PubTator, text mining | PubMed |
| Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. | Cancers (Basel) | 2020 | 32635175 | PubTator, text mining | PubMed |
| B-cell maturation antigen expression across hematologic cancers: a systematic literature review. | Blood Cancer J | 2020 | 32606424 | PubTator, text mining | PubMed |
| COVID-19 among fit patients with CLL treated with venetoclax-based combinations. | Leukemia | 2020 | 32601378 | PubTator, text mining | PubMed |
| The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma. | Biomed Res Int | 2020 | 32596371 | PubTator, text mining | PubMed |
| Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region. | Front Oncol | 2020 | 32587827 | PubTator, text mining | PubMed |
| Clinical Relevance of +936 C>T VEGFA and c.233C>T bFGF Polymorphisms in Chronic Lymphocytic Leukemia. | Genes (Basel) | 2020 | 32585853 | PubTator, text mining | PubMed |
| Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects. | Onco Targets Ther | 2020 | 32581549 | PubTator, text mining | PubMed |
| Chronic Lymphocytic Leukemia: Real-World Data From India. | JCO Glob Oncol | 2020 | 32579486 | PubTator, text mining | PubMed |
| Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement. | Br J Haematol | 2020 | 32578872 | PubTator, text mining | PubMed |
| Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL. | Cells | 2020 | 32570839 | PubTator, text mining | PubMed |
| Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing. | Leukemia | 2020 | 32561841 | PubTator, text mining | PubMed |
| Genomic deregulation of PRMT5 supports growth and stress tolerance in chronic lymphocytic leukemia. | Sci Rep | 2020 | 32555249 | PubTator, text mining | PubMed |
| Tumor Lysis Syndrome Caused by Unrecognized Richter's Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression. | Cureus | 2020 | 32550064 | PubTator, text mining | PubMed |
| Management of Drug Resistance in Mantle Cell Lymphoma. | Cancers (Basel) | 2020 | 32545704 | PubTator, text mining | PubMed |
| Frontline Therapy of Chronic Lymphocytic Leukemia: Changing Treatment Paradigm. | Curr Hematol Malig Rep | 2020 | 32542586 | PubTator, text mining | PubMed |
| Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients. | Front Immunol | 2020 | 32536913 | PubTator, text mining | PubMed |
| Neutralizing antibodies in convalescent patients. | Nat Rev Immunol | 2020 | 32533112 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=58